FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
07/28/2026
Back to search
Official data from USPTO
BIO CITY
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
BIO CITY
ST13
US500000079423791Class
5, 42, 44
Filing
79423791
Registration
8226743
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
07/28/2026
Trademark type
Word
Nice classes
5, 42, 44
Filing date
03/21/2025
Registration date
04/28/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/28/2026
Last transaction
07/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
16
Owner location
LT
Examiner
MANCA, ALBERTO I
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
UAB "Northway turto valdymas"
Representatives
John Zaccaria Notaro, Michalos & Zaccaria P.C.
Technical classification
Nice Classes
Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the treatment of oncologicalcardiovascularrespiratoryinflammatoryautoimmune and degenerative diseases and disordersrheumatoid arthritismultiple sclerosisallergies and COVID-19; drugs for medical purposespharmaceutical preparations for the treatment of oncologicalcardiovascularrespiratoryinflammatoryautoimmune and degenerative diseases and disordersrheumatoid arthritismultiple sclerosisallergies and COVID-19; biological preparations for medical purposes for the treatment of oncologicalcardiovascularrespiratoryinflammatoryautoimmune and degenerative diseases and disordersrheumatoid arthritismultiple sclerosisallergies and COVID-19; biological tissue cultures for medical purposes for the treatment of oncologicalcardiovascularrespiratoryinflammatoryautoimmune and degenerative diseases and disordersrheumatoid arthritismultiple sclerosisallergies and COVID-19; chemical preparations for medical purposes for the treatment of oncologicalcardiovascularrespiratoryinflammatoryautoimmune and degenerative diseases and disordersrheumatoid arthritismultiple sclerosisallergies and COVID-19
Class 42
Scientific and technological services and research and design relating theretoscientific research and product design in the field of development of biotechnology products and processes; bacteriological research; biological research; chemistry services in the nature of product development and quality control of biotechnology products; chemical research; medical and scientific researchconducting clinical trials for others; scientific research; medical research; scientific laboratory services; technical research in the field of pharmaceutical studies; technological consultancy in the technology field of development of manufacturing processes for biotechnology products
Class 44
Medical services; alternative medicine services; in vitro fertilization services; occupational therapy services; human tissue bank services; rental of medical equipment; medical analysis services for diagnostic and treatment of persons provided by medical laboratories
Publications
History of USPTO decisions and trademark events.
20 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/28/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
04/28/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/10/2026
PUBO
PUBLISHED FOR OPPOSITION
03/10/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/04/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/16/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/11/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/11/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/11/2026
RFNT
REFUSAL PROCESSED BY IB
10/24/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/07/2025
RFRR
REFUSAL PROCESSED BY MPU
10/07/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
08/24/2025
CNRT
NON-FINAL ACTION WRITTEN
08/23/2025
DOCK
ASSIGNED TO EXAMINER
08/20/2025
MAFR
APPLICATION FILING RECEIPT MAILED
05/28/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/28/2025
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
05/28/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
05/15/2025
Continuous trademark protection
Get notified about every new filing that threatens BIO CITY or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.